ABT vs. TMO
ABT (Abbott Laboratories) and TMO (Thermo Fisher Scientific Inc.) are both stocks. Both are in the Healthcare sector — ABT in Medical Devices, TMO in Diagnostics & Research. Over the past 10 years, ABT returned 11.01%/yr vs 13.19%/yr for TMO. At a 0.33 correlation, their price movements are largely independent.
Performance
ABT vs. TMO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABT achieves a -17.35% return, which is significantly lower than TMO's -9.00% return. Over the past 10 years, ABT has underperformed TMO with an annualized return of 11.01%, while TMO has yielded a comparatively higher 13.19% annualized return.
ABT
- 1D
- 0.97%
- 1M
- 15.81%
- 6M
- -15.38%
- YTD
- -17.35%
- 1Y
- -15.90%
- 3Y*
- -1.80%
- 5Y*
- -1.19%
- 10Y*
- 11.01%
- ALL TIME*
- 12.69%
TMO
- 1D
- -1.17%
- 1M
- 13.26%
- 6M
- -14.78%
- YTD
- -9.00%
- 1Y
- 27.34%
- 3Y*
- -1.87%
- 5Y*
- 0.74%
- 10Y*
- 13.19%
- ALL TIME*
- 12.05%
ABT vs. TMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | -17.35% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
TMO Thermo Fisher Scientific Inc. | -9.00% | 11.78% | -1.72% | -3.36% | -17.29% | 43.54% | 43.72% | 45.55% | 18.21% | 35.03% |
Correlation
The correlation between ABT and TMO is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.49 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Sep 1, 1987 | 0.33 |
The correlation between ABT and TMO shifts across timeframes, from 0.33 (1 year) to 0.56 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
ABT:
$177.18B
TMO:
$195.56B
ABT:
$3.59
TMO:
$18.24
ABT:
28.31
TMO:
28.85
ABT:
3.94
TMO:
4.38
ABT:
2.69
TMO:
3.78
ABT:
$45.13B
TMO:
$45.20B
ABT:
$25.45B
TMO:
$17.81B
ABT:
$10.80B
TMO:
$11.16B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABT vs. TMO — Risk / Return Rank
ABT
TMO
ABT vs. TMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABT | TMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.49 | ||
| Sortino ratioReturn per unit of downside risk | -2.25 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.18 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.41 | 0.88 | -1.29 |
| Martin ratioReturn relative to average drawdown | -0.81 | 1.74 | -2.54 |
Loading charts...
Drawdowns
ABT vs. TMO - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum TMO drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for ABT and TMO.
Loading charts...
Drawdown Indicators
| ABT | TMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.66% | -71.16% | +25.50% |
Max Drawdown (1Y)Largest decline over 1 year | -38.61% | -31.38% | -7.23% |
Max Drawdown (3Y)Largest decline over 3 years | -39.64% | -37.28% | -2.36% |
Max Drawdown (5Y)Largest decline over 5 years | -39.64% | -40.95% | +1.31% |
Max Drawdown (10Y)Largest decline over 10 years | -39.64% | -40.95% | +1.31% |
Current DrawdownCurrent decline from peak | -25.15% | -20.09% | -5.06% |
Average DrawdownAverage peak-to-trough decline | -10.89% | -18.12% | +7.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.72% | 15.79% | +3.93% |
Volatility
ABT vs. TMO - Volatility Comparison
Abbott Laboratories (ABT) has a higher volatility of 12.84% compared to Thermo Fisher Scientific Inc. (TMO) at 7.76%. This indicates that ABT's price experiences larger fluctuations and is considered to be riskier than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABT | TMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.84% | 7.76% | +5.08% |
Volatility (6M)Calculated over the trailing 6-month period | 23.29% | 22.95% | +0.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.21% | 31.33% | -5.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.82% | 27.37% | -4.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.92% | 26.42% | -2.50% |
Dividends
ABT vs. TMO - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 2.44%, more than TMO's 0.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.44% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
TMO Thermo Fisher Scientific Inc. | 0.34% | 0.30% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% |
Financials
ABT vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABT vs. TMO - Profitability Comparison
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.
TMO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Thermo Fisher Scientific Inc. reported a gross profit of 4.48B and revenue of 11.01B. Therefore, the gross margin over that period was 40.7%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.
TMO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Thermo Fisher Scientific Inc. reported an operating income of 1.86B and revenue of 11.01B, resulting in an operating margin of 16.9%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.
TMO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Thermo Fisher Scientific Inc. reported a net income of 1.65B and revenue of 11.01B, resulting in a net margin of 15.0%.
Frequently Asked Questions
ABT and TMO have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABT has higher volatility (12.84%) compared to TMO (7.76%). In terms of maximum drawdown, ABT dropped -45.66% vs TMO's -71.16%.
TMO currently has the higher Sharpe Ratio (0.88 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABT and TMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer